SCHEMBL23895698

SCHEMBL23895698

O=C1CCCN1COI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9947452 0.82 PIK3CD (0.52)
SCHEMBL1829052 0.78
SCHEMBL9947459 0.78 CHRM2 (0.48)
SCHEMBL9947460 0.77 KMT2A (0.49)
SCHEMBL4401731 0.77
SCHEMBL9947443 0.76 L3MBTL1 (0.47)
SCHEMBL188184 0.75
SCHEMBL1491233 0.75
SCHEMBL9947456 0.74 L3MBTL1 (0.50)
SCHEMBL8536422 0.74 L3MBTL1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021203028-A1 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-10-07 WO disclosed